DK0640614T3 - Stereoselektiv fremgangsmåde til fremstilling af beta-anomerberigede 2-deoxy-2,2-difluor-D-ribofuranosyl-3,5-hydroxybeskyttede 1-alkyl- og arylsulfonatmellemprodukter - Google Patents

Stereoselektiv fremgangsmåde til fremstilling af beta-anomerberigede 2-deoxy-2,2-difluor-D-ribofuranosyl-3,5-hydroxybeskyttede 1-alkyl- og arylsulfonatmellemprodukter

Info

Publication number
DK0640614T3
DK0640614T3 DK94306253.9T DK94306253T DK0640614T3 DK 0640614 T3 DK0640614 T3 DK 0640614T3 DK 94306253 T DK94306253 T DK 94306253T DK 0640614 T3 DK0640614 T3 DK 0640614T3
Authority
DK
Denmark
Prior art keywords
ribofuranosyl
deoxy
difluoro
alkyl
intermediates
Prior art date
Application number
DK94306253.9T
Other languages
English (en)
Inventor
Charles David Jones
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0640614T3 publication Critical patent/DK0640614T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94306253.9T 1993-08-25 1994-08-24 Stereoselektiv fremgangsmåde til fremstilling af beta-anomerberigede 2-deoxy-2,2-difluor-D-ribofuranosyl-3,5-hydroxybeskyttede 1-alkyl- og arylsulfonatmellemprodukter DK0640614T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/111,578 US5424416A (en) 1993-08-25 1993-08-25 Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides

Publications (1)

Publication Number Publication Date
DK0640614T3 true DK0640614T3 (da) 1997-04-14

Family

ID=22339311

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94306253.9T DK0640614T3 (da) 1993-08-25 1994-08-24 Stereoselektiv fremgangsmåde til fremstilling af beta-anomerberigede 2-deoxy-2,2-difluor-D-ribofuranosyl-3,5-hydroxybeskyttede 1-alkyl- og arylsulfonatmellemprodukter

Country Status (9)

Country Link
US (1) US5424416A (da)
EP (1) EP0640614B1 (da)
JP (1) JP3659989B2 (da)
AT (1) ATE145916T1 (da)
CA (1) CA2130618C (da)
DE (1) DE69401045T2 (da)
DK (1) DK0640614T3 (da)
ES (1) ES2094623T3 (da)
GR (1) GR3022477T3 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521294A (en) * 1995-01-18 1996-05-28 Eli Lilly And Company 2,2-difluoro-3-carbamoyl ribose sulfonate compounds and process for the preparation of beta nucleosides
DK1058686T3 (da) * 1998-02-25 2007-03-05 Univ Emory 2'-fluornukleosider
WO2003000200A2 (en) 2001-06-22 2003-01-03 Pharmasset Ltd. β-2'-OR 3'-HALONUCLEOSIDES
US6884880B2 (en) * 2002-08-21 2005-04-26 Ash Stevens, Inc. Process for the preparation of 9-β-anomeric nucleoside analogs
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
TW200606159A (en) * 2004-07-30 2006-02-16 Pharmaessentia Corp Stereoselective synthesis of β-nucleosides
WO2006119347A1 (en) * 2005-05-02 2006-11-09 Pharmaessentia Corp. STEREOSELECTIVE SYNTHESIS OF β-NUCLEOSIDES
US8895531B2 (en) * 2006-03-23 2014-11-25 Rfs Pharma Llc 2′-fluoronucleoside phosphonates as antiviral agents
US8193339B2 (en) * 2007-11-06 2012-06-05 Pharmaessentia Corp. Synthesis of β-nucleosides
US20090274686A1 (en) * 2008-05-02 2009-11-05 Yat Sun Or Nucleoside phosphonate derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
DE2628202A1 (de) * 1976-06-23 1977-12-29 Max Planck Gesellschaft Verfahren zur herstellung von 2'-substituierten-d-ribofuranosylpurinderivaten
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
FR2531962B1 (fr) * 1982-08-17 1986-11-14 Sandoz Sa Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4625020A (en) * 1983-11-18 1986-11-25 Bristol-Myers Company Nucleoside process
DE3587500T2 (de) * 1984-12-04 1993-12-16 Lilly Co Eli Tumorbehandlung bei Säugetieren.
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
EP0339161A1 (en) * 1988-04-01 1989-11-02 Merrell Dow Pharmaceuticals Inc. Novel fluorophosphonate nucleotide derivatives
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів

Also Published As

Publication number Publication date
EP0640614B1 (en) 1996-12-04
JP3659989B2 (ja) 2005-06-15
ATE145916T1 (de) 1996-12-15
DE69401045T2 (de) 1997-04-10
GR3022477T3 (en) 1997-05-31
CA2130618A1 (en) 1995-02-26
US5424416A (en) 1995-06-13
CA2130618C (en) 2006-02-14
EP0640614A3 (en) 1995-05-03
ES2094623T3 (es) 1997-01-16
DE69401045D1 (de) 1997-01-16
EP0640614A2 (en) 1995-03-01
JPH07165782A (ja) 1995-06-27

Similar Documents

Publication Publication Date Title
DK0629608T3 (da) Fremgangsmåde til fremstilling af N-acyl-N,N',N'-ethylendiamintrieddikesyrederivater
DK0576231T3 (da) Proces til fremstilling af alfa-anomerberigede 1-halogen-2-deoxy-2, 2-difluor-D-ribofuranosylderivater
BR9302428A (pt) Processo estereosseletivo a baixa temperatura para preparar um derivado enriquecido de riboturanosila alfa-anomero e o derivado obitdo
DK196586A (da) Makrolidantibiotika
DK0577302T3 (da) Fremgangsmåde til fremstilling af alfa-anomerberigede 2-deoxy-2,2-difluor-D-ribofuranosylsulfornater
DK0640614T3 (da) Stereoselektiv fremgangsmåde til fremstilling af beta-anomerberigede 2-deoxy-2,2-difluor-D-ribofuranosyl-3,5-hydroxybeskyttede 1-alkyl- og arylsulfonatmellemprodukter
DK321888A (da) Anvendelse af jordalkalisalte af ethercarboxylsyr er som katalysatorer til alkoxylering
DK588286D0 (da) Fremgangsmaade til fremstilling af 5-(2,5-dimethylphenoxy)-2,2-dimethylpentansyre
DK533881A (da) Fremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxidazol-2-oxider eller farmekologisk acceptable syreadditionsforbindelser
DK436685A (da) Fremgangsmaade til fremstilling af 2,4-dichlor-5-fluor-benzoesyre
DK150684C (da) Fremgangsmaade til fremstilling af anthocyaner ved reduktion af de tilsvarende flavonoidglycosider
DK0576228T3 (da) Fremgangsmåde til fremstilling af beta-anomer-berigede 2-deoxy-2,2-difluor-D-ribofuranosyl-arylsulfonater
DK433987D0 (da) Fremgangsmaade til fremstilling af 1,12-dodecandisyre ii
DK0483459T3 (da) Fremgangsmåde til fremstilling af phosphatidylcholinderivater
DK0711764T3 (da) Fremgangsmåde til fremstilling af L-ascorbinsyre
DK0399748T3 (da) Fremgangsmåde til fremstilling af 2-oxindol-1-carboxamider
DK0661263T3 (da) Fremgangsmåde til fremstilling af 2,4,5-tribrompyrrol-3-carbonitril
DK434689D0 (da) Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater
DK0450491T3 (da) Fremgangsmåde til fremstilling af d-isocitronsyre ved fermentation
DK309080A (da) Fremgangsmaade til fremstilling af 3-(2,2-dichlorvinyl)-2,2-dimethyl-cyclopropan-1-carboxylsyrederivater
DK281587D0 (da) Fremgangsmaade til fremstilling af l-isoleucin ud fra d,l- alfa-hydroxybutyrat ved fermentering.
DK239387D0 (da) Fremgangsmaade til fremstilling af 3-alkoxy- eller 3,3-dialkoxycarboxylsyreestere
FR2601000B1 (fr) Procede de radio-iodation de gangliosides par voie enzymatique
IT7829038A0 (it) Processo di regolazione per impianto di riscaldamento centrale di edificio.
IT7827750A0 (it) Processo per la preparazione di derivati 1,4-diidro-piridinici.